Based on the results seen in Figure 3, SPAG6 and SPAG16 expressions were significantly increased in the ME treatment compared with the LE treatment, while SPAG6 was also significantly upregulated in the ME treatment compared with HE. This evidence concerns the gene SPAG16 and hereditary elliptocytosis.